Literature DB >> 7715709

RNA polymerase II C-terminal domain required for enhancer-driven transcription.

H P Gerber1, M Hagmann, K Seipel, O Georgiev, M A West, Y Litingtung, W Schaffner, J L Corden.   

Abstract

The RNA polymerase II carboxy-terminal domain (CTD) consists of tandem repeats of the sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser. The CTD may participate in activated transcription through interaction with a high-molecular-weight mediator complex. Such a role would be consistent with observations that some genes are preferentially sensitive to CTD mutations. Here we investigate the function of the mouse RNA polymerase CTD in enhancer-driven transcription. Transcription by alpha-amanitin-resistant CTD-deletion mutants was tested by transient transfection of tissue culture cells in the presence of alpha-amanitin in order to inhibit endogenous RNA polymerase II. Removal of most of the CTD abolishes transcriptional activation by all enhancers tested, whereas transcription from promoters driven by Sp1, a factor that typically activates housekeeping genes from positions proximal to the initiation sites, is not affected. These findings show that the CTD is essential in mediating 'enhancer'-type activation of mammalian transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715709     DOI: 10.1038/374660a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  78 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

3.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Dynamic association of capping enzymes with transcribing RNA polymerase II.

Authors:  S C Schroeder; B Schwer; S Shuman; D Bentley
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 5.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

6.  Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.

Authors:  M Rossignol; I Kolb-Cheynel; J M Egly
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

7.  A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3' end processing.

Authors:  Nova Fong; Gregory Bird; Marc Vigneron; David L Bentley
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Authors:  Emanuel Rosonina; Benjamin J Blencowe
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

9.  Prolonged α-amanitin treatment of cells for studying mutated polymerases causes degradation of DSIF160 and other proteins.

Authors:  David C Tsao; Noh Jin Park; Anita Nag; Harold G Martinson
Journal:  RNA       Date:  2011-12-22       Impact factor: 4.942

10.  Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast.

Authors:  J B McNeil; H Agah; D Bentley
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.